Health Provider Information about the Vaping and E-Cigarettes Pulmonary Disease
Multiple states across the country have reported clusters of patients experiencing severe respiratory disease after using e-cigarette or vapor products, also known as EVALI (e-cigarette, or vaping, product use–associated lung injury). As of November 19th, 2019, 2,172 cases have been reported across 49 states, the District of Columbia and two U.S. territories (Puerto Rico and U.S, Virgin Islands). 42 deaths have been confirmed.
As of November 19th, 2019, state and local public health officials in Ohio have confirmed 60 cases of vaping-related severe pulmonary illness and are investigating an additional 34 reports of illness among patients experiencing serious respiratory symptoms following e-cigarette or vaping product use. 55 of the 60 individuals were hospitalized (92%) and there have been 0 deaths in Ohio.
Here are some documents that will help with the new reporting of this disease:
- CDC MMWR Vaping Update - Characteristics of E-cigarette, or Vaping, Products Used by Patients with Associated Lung Injury and Products Seized by Law Enforcement — Minnesota, 2018 and 2019 (11/26/2019)
- CDC MMWR Vaping Update - Interim Guidance for Health Care Providers (11/19/2019)
- CDC MMWR Vaping Update - Characteristics of Hospitalized and Nonhospitalized Patients (11/19/2019)
- CDC MMWR Vaping Update (10/28/2019)
- CCCHD Health Alert (10/1/2019)
- Clinician Report Form (9/26/2019)
- Directors Journal Entry - ODH (9/30/2019)
- ODH Health Alert (9/30/2019)
- CDC Previous Guidance of Disease (8/30/2019)
More Vaping information:
- Ohio Department of Health (ODH) Vaping Investigation
- Centers for Disease Control and Prevention (CDC) Vaping Information
Last Review: 11-26-19 BCH
